For example, the replacement of picolinamide with sulfonylphenyl [56], methoxyphenyl [57], cyanophenyl [58], and chlorophenyl [59] in the hinge region resulted in maintaining inhibitory activities toward cancer cell lines including HepG2, and kinases including VEGFR-2 and B-Raf. This evidence concerns the gene BRAF and cancer.